Editorial
doi: 10.1016/j.jhep.2021.01.030.
Epub 2021 Feb 19.
CD40-agonist: A new avenue for immunotherapy combinations in cholangiocarcinoma
Affiliations
- PMID: 33612309
- DOI: 10.1016/j.jhep.2021.01.030
Item in Clipboard
Editorial
CD40-agonist: A new avenue for immunotherapy combinations in cholangiocarcinoma
J Hepatol.
2021 May.
No abstract available
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma.J Hepatol. 2021 May;74(5):1145-1154. doi: 10.1016/j.jhep.2020.11.037. Epub 2020 Dec 1. J Hepatol. 2021. PMID: 33276030 Free PMC article.
Similar articles
-
MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma.Cell Mol Gastroenterol Hepatol. 2021;12(3):1153-1154. doi: 10.1016/j.jcmgh.2021.06.019. Epub 2021 Jul 6. Cell Mol Gastroenterol Hepatol. 2021. PMID: 34242622 Free PMC article. No abstract available.
-
[The progress of chemotherapy for intrahepatic cholangiocarcinoma].Nihon Shokakibyo Gakkai Zasshi. 2012 Nov;109(11):1895-901. Nihon Shokakibyo Gakkai Zasshi. 2012. PMID: 23132033 Review. Japanese. No abstract available.
-
Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials.JCO Precis Oncol. 2023 Apr;7:e2200573. doi: 10.1200/PO.22.00573. JCO Precis Oncol. 2023. PMID: 37053534 Free PMC article. Review. No abstract available.
-
[Systemic chemotherapy for cholangiocarcinoma].Nihon Shokakibyo Gakkai Zasshi. 2010 Jul;107(7):1102-8. Nihon Shokakibyo Gakkai Zasshi. 2010. PMID: 20616478 Review. Japanese. No abstract available.
-
[Photodynamic therapy for unresectable cholangiocarcinoma: does it really increase the survival time?].Korean J Gastroenterol. 2005 Jun;45(6):446; author reply 447. Korean J Gastroenterol. 2005. PMID: 15973081 Korean. No abstract available.
Cited by
-
Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma.Front Oncol. 2021 Oct 25;11:757919. doi: 10.3389/fonc.2021.757919. eCollection 2021. Front Oncol. 2021. PMID: 34760703 Free PMC article.
-
Advances in CAR T-cell therapy in bile duct, pancreatic, and gastric cancers.Front Immunol. 2022 Oct 6;13:1025608. doi: 10.3389/fimmu.2022.1025608. eCollection 2022. Front Immunol. 2022. PMID: 36341440 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
